Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Breast (Edinburgh, Scotland)|July 5, 2021
Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise studyEija Roine, Harri Sintonen, Pirkko-Liisa Kellokumpu-Lehtinen, et al.
The Breast Journal|January 1, 2025
Digital Self-Management Intervention Paths for Early Breast Cancer Patients: Results of a Pilot StudyPaula Poikonen-Saksela, Evangelos Karademas, Leena Vehmanen, et al.
Acta Oncologica (Stockholm, Sweden)|October 9, 2025
Impact of the COVID-19 pandemic on the quality of life of early breast cancer patients undergoing adjuvant chemotherapy - an observational, multicenter studyMarie Tuomarila, Paula Poikonen-Saksela, Haridimos Kondylakis, et al.
Anticancer Research|April 9, 2013
Obesity and physical inactivity are related to impaired physical health of breast cancer survivorsAnneli Elme, Meri Utriainen, Pirkko Kellokumpu-Lehtinen, et al.
JAMA Network Open|August 26, 2024
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical TrialHeikki Joensuu, Judith Fraser, Hans Wildiers, et al.
Anticancer Research|September 21, 2012
Effectiveness of a 12-month exercise program on physical performance and quality of life of breast cancer survivorsTiina Saarto, Heidi Marika Penttinen, Harri Sievänen, et al.
JAMA Oncology|June 1, 2018
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical TrialHeikki Joensuu, Judith Fraser, Hans Wildiers, et al.
JMIR Research Protocols|October 12, 2022
Predicting Effective Adaptation to Breast Cancer to Help Women BOUNCE Back: Protocol for a Multicenter Clinical Pilot StudyGreta Pettini, Virginia Sanchini, Ruth Pat-Horenczyk, et al.
Future Oncology (London, England)|October 21, 2024
Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patientsAntonis Valachis, Laura Biganzoli, Athina Christopoulou, et al.
Pageof 2